These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6154430)
1. Pseudomonas aeruginosa allergy in cystic fibrosis. Involvement of histamine release in the pathogenesis of lung tissue damage. Skov PS; Norn S; Schiøtz PO; Permin H; Høiby N Allergy; 1980 Jan; 35(1):23-9. PubMed ID: 6154430 [TBL] [Abstract][Full Text] [Related]
2. Histamine release from basophils in cystic fibrosis. Schönfeld W; Saak A; Steinkamp G; Van der Hardt H; König W Clin Exp Immunol; 1989 Jun; 76(3):434-9. PubMed ID: 2473860 [TBL] [Abstract][Full Text] [Related]
3. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection. Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889 [TBL] [Abstract][Full Text] [Related]
4. Platelet 3H-serotonin releasing immune complexes induced by Pseudomonas aeruginosa in cystic fibrosis. Permin H; Skov PS; Norn S; Høiby N; Schiøtz PO Allergy; 1982 Feb; 37(2):93-100. PubMed ID: 7137525 [TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases. Holby N; Olling S Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841 [TBL] [Abstract][Full Text] [Related]
6. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis. Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157 [TBL] [Abstract][Full Text] [Related]
7. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330 [TBL] [Abstract][Full Text] [Related]
8. Specific Pseudomonas immunoglobulin E antibodies in sera of patients with cystic fibrosis. Shen J; Brackett R; Fischer T; Holder A; Kellogg F; Michael JG Infect Immun; 1981 May; 32(2):967-8. PubMed ID: 6788704 [TBL] [Abstract][Full Text] [Related]
9. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Brett MM; Ghoneim AT; Littlewood JM Arch Dis Child; 1986 Nov; 61(11):1114-20. PubMed ID: 3098186 [TBL] [Abstract][Full Text] [Related]
10. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Pedersen SS; Høiby N; Espersen F; Koch C Thorax; 1992 Jan; 47(1):6-13. PubMed ID: 1539148 [TBL] [Abstract][Full Text] [Related]
11. Quantitative studies on immunologically specific and non-specific absorption of Pseudomonas aeruginosa antibodies in serum from cystic fibrosis patients. Høiby N; Hertz JB Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):185-92. PubMed ID: 6797245 [TBL] [Abstract][Full Text] [Related]
12. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis. Jensen P; Johansen HK; Lanng S; Høiby N Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271 [TBL] [Abstract][Full Text] [Related]
13. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. Pedersen SS APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848 [TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa: immune status in patients with cystic fibrosis. Doggett RG; Harrison GM Infect Immun; 1972 Oct; 6(4):628-35. PubMed ID: 4628901 [TBL] [Abstract][Full Text] [Related]
15. Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis. Gaweł J; Pogorzelski A; Działek-Smętek E; Sochań B; Ligarska R; Lącka M; Mazurek H Pneumonol Alergol Pol; 2014; 82(4):336-41. PubMed ID: 24964236 [TBL] [Abstract][Full Text] [Related]
16. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization]. Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418 [TBL] [Abstract][Full Text] [Related]
17. Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis. Weisner AM; Chart H; Bush A; Davies JC; Pitt TL J Med Microbiol; 2007 May; 56(Pt 5):670-674. PubMed ID: 17446292 [TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide. Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264 [TBL] [Abstract][Full Text] [Related]
19. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. Meluleni GJ; Grout M; Evans DJ; Pier GB J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254 [TBL] [Abstract][Full Text] [Related]
20. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis. Pressler T; Jensen ET; Espersen F; Pedersen SS; Høiby N; Koch C Pediatr Pulmonol; 1994 Jan; 17(1):31-40. PubMed ID: 8108174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]